These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24439736)

  • 21. The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.
    Zlotnick GW; Jones TR; Liberator P; Hao L; Harris S; McNeil LK; Zhu D; Perez J; Eiden J; Jansen KU; Anderson AS
    Hum Vaccin Immunother; 2015; 11(1):5-13. PubMed ID: 25483509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningitis B vaccine to be introduced in UK after U turn on its cost effectiveness.
    Wise J
    BMJ; 2014 Mar; 348():g2327. PubMed ID: 24665138
    [No Abstract]   [Full Text] [Related]  

  • 23. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choosing a Mass Immunization Program against Meningococcal B.
    Wu K; Mulholland EK; Edwards KM
    N Engl J Med; 2020 Jan; 382(4):379-382. PubMed ID: 31971685
    [No Abstract]   [Full Text] [Related]  

  • 25. The meningococcus tamed?
    Pollard AJ; Moxon ER
    Arch Dis Child; 2002 Jul; 87(1):13-7. PubMed ID: 12089113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.
    Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV
    Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Group B meningococcal invasive infections: an unresolved public health problem].
    Crisinel PA; Posfay-Barbe KM
    Rev Med Suisse; 2011 Feb; 7(283):447-50. PubMed ID: 21452513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of meningococcal disease in a schoolgirl previously given meningococcal C vaccine.
    Pugh RN; Heseltine A
    Commun Dis Public Health; 2002 Mar; 5(1):74. PubMed ID: 12070983
    [No Abstract]   [Full Text] [Related]  

  • 29. Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation.
    Brehony C; Rodrigues CMC; Borrow R; Smith A; Cunney R; Moxon ER; Maiden MCJ
    Vaccine; 2016 Sep; 34(39):4690-4697. PubMed ID: 27521232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
    Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
    Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges and progress in the development of a serogroup B meningococcal vaccine.
    Lewis S; Sadarangani M; Hoe JC; Pollard AJ
    Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances towards the prevention of meningococcal B disease: a multidimensional story.
    Roderick M; Finn A
    J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel assessment of a novel meningitis B vaccine.
    Gill CJ
    Lancet Infect Dis; 2013 May; 13(5):381-2. PubMed ID: 23414710
    [No Abstract]   [Full Text] [Related]  

  • 34. Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016.
    Soeters HM; Dinitz-Sklar J; Kulkarni PA; MacNeil JR; McNamara LA; Zaremski E; Chang HY; Lujan E; Granoff D; Lasky M; Montana B
    Emerg Infect Dis; 2017 May; 23(5):867-869. PubMed ID: 28418307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of vaccination on meningococcal epidemiology.
    Stefanelli P; Rezza G
    Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal serogroup B outbreaks and use of 4CMenB vaccine.
    Rose WE
    J Am Pharm Assoc (2003); 2014; 54(2):198-201. PubMed ID: 24632933
    [No Abstract]   [Full Text] [Related]  

  • 37. [Meningococcal serogroup B vaccines].
    Dommergues MA
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S65-9. PubMed ID: 22883369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neisseria meningitidis B vaccines: recent advances and possible immunization policies.
    Gasparini R; Amicizia D; Domnich A; Lai PL; Panatto D
    Expert Rev Vaccines; 2014 Mar; 13(3):345-64. PubMed ID: 24476428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neisseria meningitidis serogroup B vaccine development.
    Caesar NM; Myers KA; Fan X
    Microb Pathog; 2013 Apr; 57():33-40. PubMed ID: 23416222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A universal vaccine for serogroup B meningococcus.
    Giuliani MM; Adu-Bobie J; Comanducci M; Aricò B; Savino S; Santini L; Brunelli B; Bambini S; Biolchi A; Capecchi B; Cartocci E; Ciucchi L; Di Marcello F; Ferlicca F; Galli B; Luzzi E; Masignani V; Serruto D; Veggi D; Contorni M; Morandi M; Bartalesi A; Cinotti V; Mannucci D; Titta F; Ovidi E; Welsch JA; Granoff D; Rappuoli R; Pizza M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10834-9. PubMed ID: 16825336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.